BMCS BioTech Medics Inc (PK)

BioTech Medics, Inc. (PINKSHEETS: BMCS) announced today that its SHBAN Alcohol Free Antiseptic Hand Sanitizer is featured in a published article in the December, 2009 Executive Healthcare Management magazine. This publication is distributed to over 80,000 CEO's of major hospital systems throughout North America as well as other key medical personnel.

The article demonstrates to key healthcare decision makers that there are safer and better proven alternatives to alcohol hand sanitizers. Recently the State of Michigan banned alcohol hand sanitizers in government buildings due to their flammability. A school recently burned down in Sweden from students igniting alcohol gel. A nurse recently received severe burns on her hands when a nearby spark ignited them immediately after applying alcohol gel hand sanitizer.

SHBAN® Antiseptic Hand Sanitizer is a unique and innovative product. SHBAN is a bio-degradable product superior to most antiseptics because 1) SHBAN is longer lasting, SHBAN does not stop working within 15 to 20 seconds after application (like alcohol gels); 2) SHBAN does not contain carcinogenic or environmentally damaging ingredients that are left on the skin for prolonged periods of time such as Benzalkonium Chloride (BOC), nor Triclosan®, nor thymus vulgaris or fragrance ingredients. SHBAN is non-toxic when used as directed on humans; 3) SHBAN does NOT contain alcohol which has poisoned over 22,000 children according to AAPCA; 4) SHBAN is non-staining, non-bleaching; 5) SHBAN is non-flammable and 6) SHBAN has no harmful or toxic odors. Most hand sanitizer products cannot make all of these claims. It is also essential that people buying hand sanitizers know which ones can prove that they kill the H1N1 Influenza Virus A. SHBAN has been clinically tested and demonstrated to kill the H1N1 (Swine) influenza virus as well as the H5N1 (Avian bird flu) Influenza. SHBAN's active ingredients have also been clinically tested and proven to kill HIV.

SHBAN(TM) in previous in vitro and in vivo testing has been evaluated for its antimicrobial properties against Staph. Aureus, Staph. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa. Prior research and clinical studies have been conducted at the University of TX Medical Branch, Galveston, TX; Microbiology & Biochemical Assay Laboratories - Houston, Texas; Pathology Associates, Pasadena, Texas; Texas A & M University - College of Veterinary Medicine, College Station, Texas; Baylor College of Dentistry, Dallas, TX; Allergan, Irvine, CA; Culleen Eye Institute, Baylor College of Medicine, Houston.

SHBAN sales are up significantly in 2009 and pending sales for 2010 are projected to be a record breaking for BioTech Medics. SHBAN is protected under four US Letters of Patent.

Safe Harbor: Forward-Looking Statements

This release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). The statements above have not been evaluated by the FDA. SHBAN is not intended to diagnose, treat or cure any disease.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact: Tom Wood Sr. V.P. Sales Phone: 972-849-3782